Systemic Administration of Antiretrovirals Prior to Exposure Prevents Rectal and Intravenous HIV-1 Transmission in Humanized BLT MicePaul W. Denton, J. Víctor García, Jacob D. Estes et al.|PLoS ONE|2010Cited by 166
Phase II study of cemiplimab, a human monoclonal anti-PD-1, in patients with advanced basal cell carcinoma (BCC) who experienced progression of disease on, or were intolerant of prior hedgehog pathway inhibitor (HHI) therapyKarl D. Lewis, Anjali Narwal, Matthew G. Fury et al.|Annals of Oncology|2018Cited by 3
P4.11D.04 A Phase 1/2 Study of REGN7075 (EGFRÃ-CD28) Combined with Cemiplimab (anti-PD-1) In NSCLC: Trial in Progress UpdateM.L. Johnson, Neil H. Segal, Michael D. Kinnaman et al.|Journal of Thoracic Oncology|2024Cited by 0